CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma
Yongjun Cha, Yu Jung Kim, Se-Hoon Lee, Tae-Min Kim, Seung Hong Choi, Dong-Wan Kim, Chul-Kee Park, Il Han Kim, Jee Hyun Kim, Eunhee Kim, Byungse Choi, Chae-Yong Kim, In Ah Kim, Dae Seog Heo
Cancer Research and Treatment. 2017;49(1):129-140.   Published online 2016 May 18    DOI: https://doi.org/10.4143/crt.2015.466

Excel Download

Post-bevacizumab Clinical Outcomes and the Impact of Early Discontinuation of Bevacizumab in Patients with Recurrent Malignant Glioma
Cancer Research and Treatment. 2017;49(1):129-140   Crossref logo
Link1 Link2 Link3

Bevacizumab in recurrent malignant glioma
Current Neurology and Neuroscience Reports. 2008;8(3):233-234   Crossref logo
Link1 Link2 Link3

Impact of adverse events of bevacizumab on survival outcomes of patients with recurrent glioblastoma
Journal of Clinical Neuroscience. 2020;74:36-40   Crossref logo
Link1 Link2

Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients
Radiation Oncology. 2014;9(1):   Crossref logo
Link1 Link2 Link3 Link4

Bevacizumab in Japanese patients with malignant glioma: from basic research to clinical trial
OncoTargets and Therapy. 2014;1551   Crossref logo
Link1

8747 POSTER Single Agent Bevacizumab for Recurrent Malignant Glioma
European Journal of Cancer. 2011;47:S588   Crossref logo
Link1 Link2

Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
Radiology and Oncology. 2015;49(1):80-85   Crossref logo
Link1 Link2

EP-1333: Re-recurrence pattern after re-irradiation with bevacizumab in recurrent malignant glioma
Radiotherapy and Oncology. 2015;115:S720   Crossref logo
Link1 Link2

A Single Institution's Experience with Bevacizumab in Combination with Cytotoxic Chemotherapy in Progressive Malignant Glioma
Clinical medicine. Oncology. 2008;2:CMO.S827   Crossref logo
Link1 Link2 Link3

8702 ORAL A Phase II, Multicenter, Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab Alone in Japanese Patients With Recurrent Malignant Glioma
European Journal of Cancer. 2011;47:S575   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.